Blueprint Medicines Corp (BPMC)
108.37
+13.51
(+14.24%)
USD |
NASDAQ |
May 02, 13:05
Blueprint Medicines Market Cap: 6.636B for May 2, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 01, 2024 | 5.808B |
| April 30, 2024 | 5.593B |
| April 29, 2024 | 5.701B |
| April 26, 2024 | 5.695B |
| April 25, 2024 | 5.556B |
| April 24, 2024 | 5.649B |
| April 23, 2024 | 5.651B |
| April 22, 2024 | 5.548B |
| April 19, 2024 | 5.318B |
| April 18, 2024 | 5.444B |
| April 17, 2024 | 5.412B |
| April 16, 2024 | 5.271B |
| April 15, 2024 | 5.216B |
| April 12, 2024 | 5.343B |
| April 11, 2024 | 5.649B |
| April 10, 2024 | 5.541B |
| April 09, 2024 | 5.646B |
| April 08, 2024 | 5.605B |
| April 05, 2024 | 5.612B |
| April 04, 2024 | 5.553B |
| April 03, 2024 | 5.647B |
| April 02, 2024 | 5.606B |
| April 01, 2024 | 5.904B |
| March 28, 2024 | 5.808B |
| March 27, 2024 | 5.804B |
| Date | Value |
|---|---|
| March 26, 2024 | 5.491B |
| March 25, 2024 | 5.402B |
| March 22, 2024 | 5.330B |
| March 21, 2024 | 5.514B |
| March 20, 2024 | 5.404B |
| March 19, 2024 | 5.387B |
| March 18, 2024 | 5.316B |
| March 15, 2024 | 5.542B |
| March 14, 2024 | 5.371B |
| March 13, 2024 | 5.548B |
| March 12, 2024 | 5.493B |
| March 11, 2024 | 5.478B |
| March 08, 2024 | 5.652B |
| March 07, 2024 | 5.636B |
| March 06, 2024 | 5.534B |
| March 05, 2024 | 5.491B |
| March 04, 2024 | 5.560B |
| March 01, 2024 | 5.824B |
| February 29, 2024 | 5.726B |
| February 28, 2024 | 5.845B |
| February 27, 2024 | 6.110B |
| February 26, 2024 | 5.820B |
| February 23, 2024 | 5.480B |
| February 22, 2024 | 5.266B |
| February 21, 2024 | 5.343B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
2.278B
Minimum
Feb 24 2023
6.937B
Maximum
Dec 23 2020
4.270B
Average
4.024B
Median
Market Cap Benchmarks
| Alnylam Pharmaceuticals Inc | 19.31B |
| Apellis Pharmaceuticals Inc | 5.688B |
| Ionis Pharmaceuticals Inc | 6.325B |
| Madrigal Pharmaceuticals Inc | 4.252B |
| Sarepta Therapeutics Inc | 12.63B |
Market Cap Related Metrics
| PS Ratio | 26.32 |
| Price to Book Value | 50.81 |
| Price | 108.37 |
| Earnings Yield | -7.71% |